CHOKSI LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.51 INR | +1.99% |
|
+23.67% | -2.19% |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 180.4 | 97.79 | 57.18 | 54.96 | 176.9 | 232.9 |
| Enterprise Value (EV) 1 | 295.1 | 292.2 | 388.4 | 443.4 | 545.7 | 551 |
| P/E ratio | 13.4 x | 6.11 x | -1.47 x | -2.11 x | 85.5 x | 7.26 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.58 x | 0.29 x | 0.2 x | 0.21 x | 0.59 x | 0.68 x |
| EV / Revenue | 0.95 x | 0.87 x | 1.38 x | 1.73 x | 1.82 x | 1.6 x |
| EV / EBITDA | 4.77 x | 4.11 x | 13.6 x | 12.6 x | 6.62 x | 5.73 x |
| EV / FCF | -27.3 x | -5.66 x | -3.34 x | -11.4 x | 43.3 x | -412 x |
| FCF Yield | -3.66% | -17.7% | -29.9% | -8.81% | 2.31% | -0.24% |
| Price to Book | 0.81 x | 0.41 x | 0.28 x | 0.31 x | 0.99 x | 1.1 x |
| Nbr of stocks (in thousands) | 6,965 | 6,965 | 6,965 | 6,965 | 6,965 | 6,965 |
| Reference price 2 | 25.90 | 14.04 | 8.210 | 7.890 | 25.40 | 33.44 |
| Announcement Date | 9/28/18 | 9/4/19 | 9/6/20 | 9/4/21 | 9/1/22 | 9/4/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 312 | 337.5 | 281.6 | 256.9 | 300.4 | 344.4 |
| EBITDA 1 | 61.82 | 71.07 | 28.62 | 35.25 | 82.49 | 96.24 |
| EBIT 1 | 31.71 | 35.86 | -10.19 | -4.573 | 34.66 | 47.43 |
| Operating Margin | 10.17% | 10.63% | -3.62% | -1.78% | 11.54% | 13.77% |
| Earnings before Tax (EBT) 1 | 19.33 | 22.95 | -57.14 | -28.08 | 3.67 | 37.21 |
| Net income 1 | 13.47 | 16 | -38.85 | -26.08 | 2.07 | 32.1 |
| Net margin | 4.32% | 4.74% | -13.8% | -10.15% | 0.69% | 9.32% |
| EPS 2 | 1.930 | 2.297 | -5.580 | -3.744 | 0.2972 | 4.609 |
| Free Cash Flow 1 | -10.81 | -51.57 | -116.1 | -39.05 | 12.6 | -1.338 |
| FCF margin | -3.47% | -15.28% | -41.24% | -15.2% | 4.19% | -0.39% |
| FCF Conversion (EBITDA) | - | - | - | - | 15.27% | - |
| FCF Conversion (Net income) | - | - | - | - | 608.7% | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 9/28/18 | 9/4/19 | 9/6/20 | 9/4/21 | 9/1/22 | 9/4/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 115 | 194 | 331 | 388 | 369 | 318 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.855 x | 2.735 x | 11.57 x | 11.02 x | 4.471 x | 3.305 x |
| Free Cash Flow 1 | -10.8 | -51.6 | -116 | -39.1 | 12.6 | -1.34 |
| ROE (net income / shareholders' equity) | 6.19% | 6.9% | -17.6% | -13.7% | 1.16% | 16.5% |
| ROA (Net income/ Total Assets) | 4.65% | 4.48% | -1.06% | -0.44% | 3.31% | 4.75% |
| Assets 1 | 290 | 357.1 | 3,671 | 5,995 | 62.51 | 675.6 |
| Book Value Per Share 2 | 32.20 | 34.50 | 29.00 | 25.50 | 25.70 | 30.30 |
| Cash Flow per Share 2 | 1.360 | 0.3300 | 0.6100 | 0.4400 | 0.5800 | 0.4800 |
| Capex 1 | 48.3 | 97.4 | 140 | 80.6 | 26.8 | 39.5 |
| Capex / Sales | 15.47% | 28.87% | 49.7% | 31.37% | 8.92% | 11.48% |
| Announcement Date | 9/28/18 | 9/4/19 | 9/6/20 | 9/4/21 | 9/1/22 | 9/4/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -2.19% | 5.55M | |
| +14.61% | 17.2B | |
| 0.00% | 6.8B | |
| -12.39% | 2.88B | |
| -11.15% | 2.72B | |
| -31.21% | 1.74B | |
| +5.00% | 1.25B | |
| -7.31% | 1.06B | |
| -6.67% | 870M | |
| -4.08% | 794M |
- Stock Market
- Equities
- CHOKSILA6 Stock
- Financials Choksi Laboratories Limited
